(MSN Health) — GlaxoSmithKline has recalled 394,230 bottles of its DynaCirc CR hypertension drug from the U.S. market after the manufacturer, Novartis, reported inconsistent packaging practices.
The generic drug is manufactured at a Novartis plant in Lincoln, Nebraska.
Glaxo said in a statement that it has received no reports of adverse events, nor any complaints of contamination or tablet mix-ups in batches of the drug, but decided on the recall as a precautionary measure.
Loading ...
Loading ...